AHMEDABAD, 10 NOVEMBER: અગ્રણી બ્રોકરેજ હાઉસ તથા ફંડ હાઉસ તરફથી પસંદગીના સ્ટોક્સમાં ખરીદી\ વેચાણ\ હોલ્ડ કરવા માટે ભલામણ કરવામાં આવી છે. તે રોકાણકારોના અભ્યાસ માટે અત્રે રજૂ કરીએ છીએ.

MS on Nykaa: Maintain Overweight on Company, raise target price at Rs 271 (Positive)

CLSA on Nykaa: Maintain Outperform on Company, raise target price at Rs 298 (Positive)

Jefferies on Hitachi Energy: Initiate Buy on Company, raise target price at Rs 25000 (Positive)

Nuvama on Hitachi Energy: Maintain Buy on Company, raise target price at Rs 26600 (Positive)

Jefferies on CG Power: Initiate Hold on Company, raise target price at Rs 745 (Positive)

Jefferies on Torrent Pharma: Maintain Buy on Company, target price at Rs 4300 (Positive)

Nuvama on Torrent Pharma: Maintain Buy on Company, target price at Rs 4180 (Positive)

Citi on Divis lab: Maintain Buy on Company, raise target price at Rs 9140 (Positive)

HSBC on Divis lab: Maintain Buy on Company, target price at Rs 7400 (Positive)

MS on Divis lab: Maintain Overweight on Company, target price at Rs 7541 (Positive)

GS on Neuland Labs: Maintain Buy on Company, target price at Rs 19700 (Positive)

Nuvama on Swiggy: Maintain Buy on Company, target price at Rs 510 (Positive)

Nuvama on Cummins: Maintain Buy on Company, raise target price at Rs 4940 (Positive)

Nuvama on Skipper: Maintain Buy on Company, target price at Rs 647 (Positive)

Nuvama on Lupin: Maintain Buy on Company, raise target price at Rs 2350 (Positive)

Nuvama on Arvind: Maintain Buy on Company, raise target price at Rs 409 (Positive)

MS on Apollo Hospitals: Maintain Overweight on Company, target price at Rs 8813 (Positive)

Nomura on Britannia: Maintain Buy on Company, target price at Rs 7000 (Positive)

GS on India Strategy: Upgrade To Overweight, See Nifty at 29,000 by 2026 End. Financials, Defence, Consumer & Tech Sectors to Lead Corp Profit Growth (Positive)

HSBC on India Strategy: HSBC reaffirms its bullish stance on Indian equities, calling India a standout opportunity among emerging markets. End-2026 Sensex target set at 94,000, reflecting confidence in broad-based growth recovery. (Positive)

HSBC on Divis lab: Maintain Neutral on Company, target price at Rs 6765 (Neutral)

Macquarie on Nykaa: Maintain Underperform on Company, target price at Rs 150 (Neutral)

GS on Amber Ent: Maintain Neutral on Company, target price at Rs 7680 (Neutral)

GS on Lupin: Maintain Neutral on Company, target price at Rs 2000 (Neutral)

MS on Cholamandalam Inv: Maintain Equal weight on Company, target price at Rs 1540 (Neutral)

MS on ICICI Pru: Maintain Equal weight on Company, target price at Rs 625 (Neutral)

Dam Cap on Bajaj Auto: Upgrade to Neutral on Company, target price at Rs 9050 (Neutral)

BofA on Bajaj Auto: Maintain Neutral on Company, target price at Rs 9300 (Neutral)

Nuvama on Bajaj Auto: Maintain Hold on Company, target price at Rs 9700 (Neutral)

Nuvama on Hindalco: Maintain Hold on Company, target price at Rs 838 (Neutral)

Nuvama on Amara Raja: Maintain Buy on Company, target price at Rs 1110 (Neutral)

CLSA on NCC: Maintain Outperform on Company, cut target price at Rs 315 (Neutral)

Jefferies on Trent: Maintain Hold on Company, cut target price at Rs 5000 (Neutral)

MS on Trent: Maintain Overweight on Company, target price at Rs 5456 (Neutral)

GS on Trent: Maintain Neutral on Company, cut target price at Rs 4920 (Neutral)

Citi on Trent: Downgrade to Sell on Company, cut target price at Rs 4350 (Negative)